Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur D Tinoco

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Inorganic Chemistry|June 24, 2017
Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer ComplexesSergio A Loza-Rosas, Alexandra M Vázquez-Salgado, Kennett I Rivero, et al.
Chemmedchem|April 26, 2026
Evaluation of Active and Passive Targeting Drug Delivery Systems as a Mechanism to Improve the Anticancer Potential of Titanium(IV)Oscar Claudio-Ares, Mallesh Pandrala, Lauren Fernández-Vega, et al.
Molecular Pharmaceutics|June 11, 2016
Combining Stimulus-Triggered Release and Active Targeting Strategies Improves Cytotoxicity of Cytochrome c Nanoparticles in Tumor CellsMoraima Morales-Cruz, Alejandra Cruz-Montañez, Cindy M Figueroa, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 3, 2023
Thin-Film Organic HeteroepitaxyJordan T Dull, Xu He, Jonathan Viereck, et al.
Inorganics|October 9, 2024
Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer ApplicationOscar Claudio-Ares, Jeileen Luciano-Rodríguez, Yolmarie L Del Valle-González, et al.
Chemmedchem|December 23, 2024
Elucidating the High Affinity Copper(II) Complexation by the Iron Chelator Deferasirox Provides Therapeutic and Toxicity InsightAixa M Orta Rivera, Luis A Landrau Correa, Selene L Schiavone-Chamorro, et al.
Inorganics|April 29, 2021
Iron and Copper Intracellular Chelation as an Anticancer Drug StrategyKavita Gaur, Alexandra M Vázquez-Salgado, Geraldo Duran-Camacho, et al.
JACS Au|July 9, 2021
Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide ReductaseKavita Gaur, Sofia C Pérez Otero, Josué A Benjamín-Rivera, et al.
Inorganics|October 9, 2024
Copper-Based Antibiotic Strategies: Exploring Applications in the Hospital Setting and the Targeting of Cu Regulatory Pathways and Current Drug Design TrendsAixa M Orta-Rivera, Yazmary Meléndez-Contés, Nataniel Medina-Berríos, et al.
Journal of Inorganic Biochemistry|April 22, 2026
Towards a dual copper(II) and iron(III) transmetalation strategy for an anticancer application with the deferasirox chelatorAixa M Orta Rivera, Andrea N Maser-Figueroa, Sergio A Loza-Rosas, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Inorganic Chemistry|June 24, 2017
Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer ComplexesSergio A Loza-Rosas, Alexandra M Vázquez-Salgado, Kennett I Rivero, et al.
Chemmedchem|April 26, 2026
Evaluation of Active and Passive Targeting Drug Delivery Systems as a Mechanism to Improve the Anticancer Potential of Titanium(IV)Oscar Claudio-Ares, Mallesh Pandrala, Lauren Fernández-Vega, et al.
Molecular Pharmaceutics|June 11, 2016
Combining Stimulus-Triggered Release and Active Targeting Strategies Improves Cytotoxicity of Cytochrome c Nanoparticles in Tumor CellsMoraima Morales-Cruz, Alejandra Cruz-Montañez, Cindy M Figueroa, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 3, 2023
Thin-Film Organic HeteroepitaxyJordan T Dull, Xu He, Jonathan Viereck, et al.
Inorganics|October 9, 2024
Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer ApplicationOscar Claudio-Ares, Jeileen Luciano-Rodríguez, Yolmarie L Del Valle-González, et al.
Chemmedchem|December 23, 2024
Elucidating the High Affinity Copper(II) Complexation by the Iron Chelator Deferasirox Provides Therapeutic and Toxicity InsightAixa M Orta Rivera, Luis A Landrau Correa, Selene L Schiavone-Chamorro, et al.
Inorganics|April 29, 2021
Iron and Copper Intracellular Chelation as an Anticancer Drug StrategyKavita Gaur, Alexandra M Vázquez-Salgado, Geraldo Duran-Camacho, et al.
JACS Au|July 9, 2021
Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide ReductaseKavita Gaur, Sofia C Pérez Otero, Josué A Benjamín-Rivera, et al.
Inorganics|October 9, 2024
Copper-Based Antibiotic Strategies: Exploring Applications in the Hospital Setting and the Targeting of Cu Regulatory Pathways and Current Drug Design TrendsAixa M Orta-Rivera, Yazmary Meléndez-Contés, Nataniel Medina-Berríos, et al.
Journal of Inorganic Biochemistry|April 22, 2026
Towards a dual copper(II) and iron(III) transmetalation strategy for an anticancer application with the deferasirox chelatorAixa M Orta Rivera, Andrea N Maser-Figueroa, Sergio A Loza-Rosas, et al.
Pageof 5